Analyst firms · Barclays · MCK

Barclays MCK price target and rating history

McKesson Corporation (MCK) · Health Care

Barclays rates McKesson Corporation (MCK) Overweight with a $960 price target, as of its latest action on Dec 9, 2025. It has published 4 rating actions on MCK since November 2021, including 0 upgrades and 0 downgrades.

Current rating
Overweight
Price target
$960
Median target, all firms
Too few
Actions on MCK
4

Barclays price target on MCK

$960$615$27020222023202420252026
Barclays price target on MCK, each point a stated target, November 2021 to December 2025.

Every Barclays rating on MCK

How other firms rate MCK

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsSector Perform$845Aug 19, 2026
William BlairOutperformApr 28, 2026
BarclaysOverweight$960Dec 9, 2025

Questions about Barclays and MCK

What is Barclays's price target for MCK?
Barclays's latest stated price target for McKesson Corporation (MCK) is $960, from its action on Dec 9, 2025.
What is Barclays's rating on MCK?
Barclays rates MCK Overweight, a bullish rating, as of Dec 9, 2025.
When did Barclays last change its view on MCK?
On Dec 9, 2025, Barclays starts coverage at Overweight, price target $960.

More MCK rating histories

All Barclays ratingsMCK news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.